An annual report — a yearly update with financials, filed after a company has raised.

Aspire BioPharma Inc.

Aspire BioPharma Inc. filed a Form C-AR — annual report — with the SEC on Apr 26, 2024.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.